Locust Walk Acquisition Corp. | Business Finance | Business Contracts

General Release of Claims, effective as of July 22, 2022, by and between eFFECTOR and Alana McNulty (Filed With SEC on August 9, 2022)

Third Amendment to Loan and Security Agreement, dated April 28, 2022, by and among eFFECTOR and Oxford Finance LLC (Filed With SEC on May 10, 2022)

Registration Rights Agreement, dated January 24, 2022, between eFFECTOR and Lincoln Park Capital Fund, LLC (Filed With SEC on January 24, 2022)

Purchase Agreement, dated January 24, 2022, between eFFECTOR and Lincoln Park Capital Fund, LLC (Filed With SEC on January 24, 2022)

eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on August 31, 2021)

Unit Subscription Agreement, dated January 7, 2021, between the Company and Locust Walk Sponsor, LLC (Filed With SEC on January 13, 2021)

Letter Agreement, dated January 7, 2021, by and among the Company and certain security holders, officers and directors of the Company (Filed With SEC on January 13, 2021)

Warrant Agreement, dated January 7, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on January 13, 2021)

Underwriting Agreement, dated January 7, 2021, between the Company and Cantor Fitzgerald & Co (Filed With SEC on January 13, 2021)

First Amendment to Promissory Note, dated December 7, 2020 (Filed With SEC on December 18, 2020)

General Release of Claims, effective as of April 8, 2022, by and between eFFECTOR and Premal Patel, M.D., Ph.D (Filed With SEC on August 9, 2022)

Second Amendment to Loan and Security Agreement, dated February 22, 2022, by and among eFFECTOR Therapeutics, Inc., eFFECTOR Therapeutics Operations, Inc. and Oxford Finance LLC (Filed With SEC on February 24, 2022)

Joinder and First Amendment to Loan and Security Agreement, dated September 7, 2021, by and among eFFECTOR Therapeutics, Inc., eFFECTOR Therapeutics Operations, Inc. and Oxford... (Filed With SEC on February 24, 2022)

Amended and Restated Registration Rights Agreement, dated August 25, 2021, by and among eFFECTOR Therapeutics, Inc., eFFECTOR Therapeutics Operations, Inc., Locust Walk Sponsor,... (Filed With SEC on August 31, 2021)

eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on August 31, 2021)

Amended and Restated Registration Rights Agreement, dated August 25, 2021, by and among eFFECTOR Therapeutics, Inc., eFFECTOR Therapeutics Operations, Inc., Locust Walk Sponsor,... (Filed With SEC on August 31, 2021)

Loan and Security Agreement, dated March 19, 2021, by and among eFFECTOR and Oxford Finance LLC and the other lenders party thereto (Filed With SEC on June 14, 2021)

Registration Rights Agreement, dated January 7, 2021, between the Company and certain security holders of the Company (Filed With SEC on January 13, 2021)

Investment Management Trust Agreement, dated January 7, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on January 13, 2021)

Specimen Common Stock Certificate (Filed With SEC on December 18, 2020)

Promissory Note dated October 6, 2020, for expenses prior to initial public offering expenses from Locust Walk Sponsor, LLC to Registrant (Filed With SEC on December 18, 2020)

Form of Letter Agreement by and between the Registrant, the Registrants security holders named therein, and the officers and directors of the Registrant (Filed With SEC on December 18, 2020)

Form of Placement Unit Subscription Agreement with Locust Walk Sponsor, LLC (Filed With SEC on December 18, 2020)

Form of Registration Rights Agreement among the Registrant and security holders (Filed With SEC on December 18, 2020)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on December 18, 2020)

Specimen Warrant Certificate (included in Exhibit 4.4) (Filed With SEC on December 18, 2020)

Form of Underwriting Agreement (Filed With SEC on December 18, 2020)

Locust Walk Acquisition Corp. (51) | Business Finance (27)